TELA Bio, Inc.
NASDAQ:TELA
0.9596 (USD) • At close April 25, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 69.3 | 58.453 | 41.418 | 29.463 | 18.213 | 15.446 | 8.274 | 4.245 |
| Cost of Revenue
| 22.812 | 18.341 | 14.374 | 10.65 | 6.979 | 6.174 | 5.332 | 1.713 |
| Gross Profit
| 46.488 | 40.112 | 27.044 | 18.813 | 11.234 | 9.272 | 2.942 | 2.532 |
| Gross Profit Ratio
| 0.671 | 0.686 | 0.653 | 0.639 | 0.617 | 0.6 | 0.356 | 0.596 |
| Reseach & Development Expenses
| 8.813 | 9.619 | 8.937 | 6.743 | 4.255 | 4.151 | 4.339 | 5.786 |
| General & Administrative Expenses
| 14.722 | 14.887 | 13.862 | 12.459 | 10.143 | 6.223 | 4.899 | 4.958 |
| Selling & Marketing Expenses
| 64.648 | 59.681 | 43.252 | 29.062 | 22.111 | 18.06 | 13.646 | 8.712 |
| SG&A
| 79.37 | 74.568 | 57.114 | 41.521 | 32.254 | 24.283 | 18.545 | 13.67 |
| Other Expenses
| -7.58 | 0 | -0.01 | -0.228 | 0.045 | 0.351 | 0.07 | 0.094 |
| Operating Expenses
| 80.603 | 84.187 | 66.051 | 48.264 | 36.509 | 28.434 | 22.884 | 19.456 |
| Operating Income
| -34.115 | -44.075 | -39.007 | -29.451 | -25.275 | -19.162 | -17.782 | -16.924 |
| Operating Income Ratio
| -0.492 | -0.754 | -0.942 | -1 | -1.388 | -1.241 | -2.149 | -3.987 |
| Total Other Income Expenses Net
| -3.87 | -2.589 | -5.289 | -3.825 | -3.519 | -3.263 | -3.31 | -4.41 |
| Income Before Tax
| -37.985 | -46.664 | -44.296 | -33.276 | -28.794 | -22.425 | -21.092 | -21.334 |
| Income Before Tax Ratio
| -0.548 | -0.798 | -1.069 | -1.129 | -1.581 | -1.452 | -2.549 | -5.026 |
| Income Tax Expense
| -0.144 | 0 | 0.041 | 2.834 | 3.084 | 3.378 | -1.508 | 4.652 |
| Net Income
| -37.841 | -46.664 | -44.337 | -36.11 | -31.878 | -25.803 | -21.092 | -21.334 |
| Net Income Ratio
| -0.546 | -0.798 | -1.07 | -1.226 | -1.75 | -1.671 | -2.549 | -5.026 |
| EPS
| -1.33 | -2.04 | -2.73 | -2.49 | -2.46 | -2.26 | -3.25 | -3.29 |
| EPS Diluted
| -1.33 | -2.04 | -2.73 | -2.49 | -2.46 | -2.26 | -3.25 | -3.29 |
| EBITDA
| -31.683 | -40.633 | -39.058 | -29.144 | -24.705 | -18.234 | -18.042 | -16.015 |
| EBITDA Ratio
| -0.457 | -0.695 | -0.943 | -0.989 | -1.356 | -1.18 | -2.181 | -3.773 |